knowledge -WSS

knowledge

author：entertainment 2025-09-30 17:28:23 - browse：93

Gavel and Stethoscope due process — District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Stanford updates investigation of president’s past research

focus

WSS

Why some people catch Covid but never get sick

Ultragenyx gene therapy for rare liver ailment succeeds in late

Why the Crimean Bridge is key to Russia's war in Ukraine

India sets sights on home

Lindsay Lohan welcomes 1st child with husband Bader Shammas

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

entertainment

knowledge

Wikipedia

Drug repurposing or repositioning? The language matters

Seattle police shoot person suspected in downtown stabbing

In Memoriam: Notable people who died in 2023

Why some people catch Covid but never get sick

Psychedelics group wrestles with new pharma identity

Ultragenyx gene therapy for rare liver ailment succeeds in late

BioMarin wins approval for gene therapy to treat hemophilia A

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Peter Hotez and the public health issue of online harassment

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

focus

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Man who had jail sentence commuted by Trump arrested again

Couple fighting to bring baby home from Mexico are finally reunited

FDA's Pazdur wants cancer trials to range beyond China alone

Ionis drug prevents swelling attacks due to hereditary angioedema

Change Healthcare can notify patients about the breach, HHS says

focus

focus

focus

explore